Case Report
Prostate Cancer and Prostatic Diseases (2005) 8, 287–289. doi:10.1038/sj.pcan.4500813; published online 7 June 2005
Case study: management of lymph node-positive disease detected at radical prostatectomy
'Casodex' and 'Zoladex' are trademarks of the AstraZeneca group of companies
Roger Kirby1
1The Prostate Centre, 32 Wimpole Street, London W1G 8GT, UK
Correspondence: R Kirby, 145 Harley Street, London W1G 6BJ, UK. E-mail: rogerkirby@compuserve.com
Received 20 May 2005; Accepted 25 May 2005; Published online 7 June 2005.
Keywords:
hormonal therapy, lymph node metastases, nerve sparing, radical prostatectomy
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Management of recurrent disease after radical prostatectomy
Prostate Cancer and Prostatic Diseases Review
Nature Clinical Practice Urology Review (01 Oct 2007)
NEWS AND VIEWS
Prostate cancer Seminal vesicle sparing: a continuing trend?
Nature Reviews Urology News and Views (01 Sep 2009)
RESEARCH
Case study: management of advanced prostate cancer with soft tissue metastases
Prostate Cancer and Prostatic Diseases Correspondence
Prostate Cancer and Prostatic Diseases Original Article
